[1] Kamijo K. Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemi-luminescence immunoassay system. Endocr J, 2010, 57(10): 895-902.  doi: 10.1507/endocrj.K10E-199
[2] 白耀.甲状腺病学-基础与临床.北京: 科学技术文献出版社, 2004: 155.
[3] Aleksic A, Aleksic Z, Stojanovic M. TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patients. Hell J Nucl Med, 2009, 12(2): 146-150.
[4] Schott M, Hermsen D, Broecker-Preuss M, et al. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease(GD): an international multicentre trial. Clin Endo-crinol(Oxf), 2009, 71(4): 566-573.  doi: 10.1111/j.1365-2265.2008.03512.x
[5] 许敏, 陆汉魁, 高云朝, 等.促甲状腺素受体抗体的两种免疫检测方法对比研究.标记免疫分析与临床, 2010, 17(4): 257-259.
[6] 朱利国, 浦洪波, 武红玉, 等.促甲状腺激素、甲状腺过氧化物酶抗体和促甲状腺激素受体抗体检测在甲状腺疾病中的应用价值.标记免疫分析与临床, 2010, 17(4): 241-243.  doi: 10.3969/j.issn.1006-1703.2010.04.013
[7] 兰玲, 施秉银.促甲状腺素受体抗体检测技术的回顾与展望.国外医学内分泌学分册, 2005, 25 (1): 45-47.
[8] Cardia MS, Lima N, Knobel M, et al. Evaluation of a coatedtube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorder. Thyroid, 2004, 14(4): 295-300.  doi: 10.1089/105072504323030951